Subscribe to these results:

Upcoming Workshops

For All Cancers

  1. Mar15CAR T-Cell Therapy: What's New
    Register
  2. Mar21Understanding How Health Care Disparities May Influence Your Cancer Treatment and Care: With Tips & Strategies to Find the Best Cancer Treatment & Health Care Team for You
    Register
  3. Mar23Understanding the Role of Immunotherapy in Treating Cancer
    Part I of New Trends in ImmunotherapyRegister

For Breast Cancer

  1. Feb24Metastatic Breast Cancer in African Americans: New Treatments
    Register

For Leukemia

  1. Mar17Chronic Lymphocytic Leukemia: What's New
    Part I of Living with Chronic Lymphocytic LeukemiaRegister
  2. Mar24Chronic Lymphocytic Leukemia: Current Treatment Perspectives
    Part II of Living with Chronic Lymphocytic LeukemiaRegister
  3. Apr 1Acute Myeloid Leukemia (AML): Treatment Updates
    Register

For Lymphoma

  1. Mar 2Diffuse Large B-Cell Lymphoma (DLBCL) Updates
    Register
  2. Mar28Follicular Lymphoma: Treatment Progress
    Register

For Mantle Cell Lymphoma

  1. Mar31Mantle Cell Lymphoma: Treatment Update
    Part I of Living with Mantle Cell Lymphoma (MCL)Register

For Prostate Cancer

  1. Mar29Metastatic Prostate Cancer: Treatment Advances
    Part I of Living with Metastatic Prostate CancerRegister

Past workshops

For All Cancers

    1. Preventing, Managing & Treating Infection in Adults Living with Cancer
    2. What’s New in Precision Medicine
    3. How Health Care Disparities May Influence Your Cancer Treatment & Care
    4. Understanding the Role of Immunotherapy in Treating Cancer
      Part I of New Trends in Immunotherapy
    5. Taking Your Pills on Schedule: Why It Is So Important in Managing Cancer
    6. Emerging Importance of Telemedicine/Telehealth Appointments in Communicating with Your Health Care Team
    7. Cancer and Flu Shots
    8. Treatment Adherence: Taking Your Pills on Schedule – Why It Is So Important
    9. What are Biosimilars? Understanding Their Role in Cancer Treatment: Current and Future Perspectives
    10. Managing the Side Effects of Immunotherapy
      Part II of New Trends in Immunotherapy
    11. Understanding the Role of Immunotherapy in Treating Cancer
      Part I of New Trends in Immunotherapy
    12. Participating in Decisions about Your Care
      Part IV of Life with Cancer: A Guide to Getting the Best Care
    13. Understanding the Costs of Care and Your Health Care Coverage
      Part II of Life with Cancer: A Guide to Getting the Best Care
    14. Taking Your Treatment on Schedule: Its Importance in Managing Cancer
    15. Care for Your Bones During & After Cancer Treatment: Tips to Improve Bone Health
    16. Participating in Decisions about Your Care
      Part V of Life with Cancer: A Guide to Getting the Best Care
    17. Medical Emergencies in Cancer Treatment

For Acute Lymphoblastic Leukemia

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    3. Transplantation as a Treatment Option for Blood Cancers
    4. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    5. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    6. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    7. Update on CAR-T Cell Therapy
    8. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    9. Taking Your Blood Cancer Treatment on Schedule
    10. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    11. Treatment Update for Adults Living with Acute Lymphocytic Leukemia (ALL)
    12. New Treatments for Childhood Acute Lymphocytic Leukemia (ALL)

For Acute Myeloid Leukemia

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    3. Transplantation as a Treatment Option for Blood Cancers
    4. Update on the Treatment of Acute Myelogenous Leukemia (AML)
    5. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    6. Update on CAR T-Cell Therapies
    7. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    8. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    9. Living with Acute Myelogenous Leukemia (AML)
    10. Update on CAR-T Cell Therapy
    11. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    12. Taking Your Blood Cancer Treatment on Schedule
    13. Updates in the Treatment of Acute Myelogenous Leukemia
    14. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

For Basal Cell Cancer

    1. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers
    2. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers
      Part I of Life with Advanced Skin Cancer

For Bladder Cancer

    1. Bladder Cancer: Treatment Updates
      Part I of Life with Bladder Cancer
    2. Update on the Treatment of Bladder Cancer
      Part I of Living with Bladder Cancer
    3. What’s New in the Treatment of Bladder Cancer
      Part I of Life with Bladder Cancer
    4. Updates on the Treatment of Bladder Cancer

For Brain Cancer

    1. Update on Glioblastoma in Adults
    2. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment
    3. Update on Glioblastoma in Adults

For Breast Cancer

    1. Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the San Antonio Breast Cancer Symposium (SABCS)
      Part II of Living with Breast Cancer, with Updates from the San Antonio Breast Cancer Symposium (SABCS)
    2. Updates from the 44th Annual San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer (TNBC)
    3. The Latest Developments Reported at the 44th Annual San Antonio Breast Cancer Symposium (SABCS)
      Part I of Living with Breast Cancer, with Updates from the San Antonio Breast Cancer Symposium (SABCS)
    4. Triple Negative Breast Cancer and African American Women
    5. HER2-Positive Metastatic Breast Cancer: New Therapies
    6. Metastatic Breast Cancer: Treatment Updates
    7. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part I of Equity. Every Patient. Every Day. Everywhere.
    8. Updates on the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive & HER2 Positive Breast Cancer from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
      Part II of Life with Breast Cancer - Updates from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
    9. The Latest Developments Reported from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
      Part I of Life with Breast Cancer - Updates from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
    10. Updates from the San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer (TNBC)
    11. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment
    12. Triple Negative Breast Cancer and African American Women
    13. What’s New in the Treatment of Breast Cancer for Women of All Ages
    14. What’s New in the Treatment of Metastatic Breast Cancer

For Cervical Cancer

    1. Cervical Cancer: Treatment Advances

For Chronic Lymphocytic Leukemia

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    3. Transplantation as a Treatment Option for Blood Cancers
    4. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    5. Update on CAR T-Cell Therapies
    6. Current Perspectives on the Treatment of Chronic Lymphocytic Leukemia (CLL)
      Part II of Living with Chronic Lymphocytic Leukemia (CLL)
    7. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    8. Update on Chronic Lymphocytic Leukemia (CLL)
      Part I of Living with Chronic Lymphocytic Leukemia (CLL)
    9. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    10. Update on CAR-T Cell Therapy
    11. Current Perspectives on the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
      Part II of Life with Chronic Lymphocytic Leukemia (CLL)
    12. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    13. Update on Chronic Lymphocytic Leukemia
      Part I of Life with Chronic Lymphocytic Leukemia (CLL)
    14. Taking Your Blood Cancer Treatment on Schedule
    15. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    16. Life with CLL: Taking Charge of Your Treatment Schedule
      Part II of Life with Chronic Lymphocytic Leukemia (CLL)

For Chronic Myelogenous Leukemia

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    3. Transplantation as a Treatment Option for Blood Cancers
    4. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    5. Update on CAR T-Cell Therapies
    6. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    7. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    8. Living with Chronic Myelogenous Leukemia (CML)
    9. Update on CAR-T Cell Therapy
    10. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    11. Taking Your Blood Cancer Treatment on Schedule
    12. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

For Colorectal Cancer

    1. Colorectal Cancer Treatment: Progress & Advances
    2. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Equity. Every Patient. Every Day. Everywhere.
    3. Advances in the Treatment of Colorectal Cancer
    4. Progress in the Treatment of Colorectal Cancer

For Cutaneous T-Cell Lymphoma

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    3. Transplantation as a Treatment Option for Blood Cancers
    4. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    5. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
    6. Update on CAR T-Cell Therapies
    7. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    8. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    9. Update on CAR-T Cell Therapy
    10. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    11. Taking Your Blood Cancer Treatment on Schedule
    12. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    13. The Emerging Role of Immunotherapy in the Treatment of Lymphoma

For Diffuse Large B-Cell Lymphoma

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    3. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
    4. Update on CAR T-Cell Therapies
    5. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    6. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    7. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
    8. Update on CAR-T Cell Therapy
    9. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    10. Taking Your Blood Cancer Treatment on Schedule
    11. Update on Diffuse Large B-Cell Lymphoma
    12. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    13. The Emerging Role of Immunotherapy in the Treatment of Lymphoma

For Endometrial Cancer

    1. Update on the Treatment of Endometrial Cancer

For Follicular Lymphoma

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    3. Transplantation as a Treatment Option for Blood Cancers
    4. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    5. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
    6. Update on CAR T-Cell Therapies
    7. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    8. Progress in the Treatment of Follicular Lymphoma
    9. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    10. Update on CAR-T Cell Therapy
    11. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    12. Taking Your Blood Cancer Treatment on Schedule
    13. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    14. The Emerging Role of Immunotherapy in the Treatment of Lymphoma

For Gastric Cancer

    1. Gastric Cancer: Treatment Updates
    2. Advances in the Treatment of Gastric Cancer
    3. Advances in the Treatment of Gastric Cancer
    4. Current Perspectives in the Treatment of Metastatic Gastric Cancer

For Gastrointestinal Stromal Tumors

    1. Advances in the Treatment of Gastrointestinal Stromal Tumors (GIST)

For Glioblastoma

    1. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part I of Equity. Every Patient. Every Day. Everywhere.
    2. Update on Glioblastoma in Adults
    3. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment
    4. Update on Glioblastoma in Adults

For Head and Neck Cancer

    1. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part I of Equity. Every Patient. Every Day. Everywhere.
    2. Treatment Update in Oral and Head and Neck Cancer
    3. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment
    4. What’s New in the Treatment of Oral and Head and Neck Cancer

For Hodgkin Lymphoma

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    3. Transplantation as a Treatment Option for Blood Cancers
    4. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    5. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    6. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
    7. Update on CAR T-Cell Therapies
    8. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    9. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    10. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    11. What’s New in the Treatment of Hodgkin Lymphoma
    12. Update on CAR-T Cell Therapy
    13. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    14. Taking Your Blood Cancer Treatment on Schedule
    15. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    16. The Emerging Role of Immunotherapy in the Treatment of Lymphoma

For Kidney Cancer

    1. Advances in the Treatment of Renal Cell Cancer

For Leukemia

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    3. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Equity. Every Patient. Every Day. Everywhere.
    4. Transplantation as a Treatment Option for Blood Cancers
    5. Progress in the Treatment of Myelofibrosis
    6. Update on the Treatment of Acute Myelogenous Leukemia (AML)
    7. Update on CAR T-Cell Therapies
    8. Current Perspectives on the Treatment of Chronic Lymphocytic Leukemia (CLL)
      Part II of Living with Chronic Lymphocytic Leukemia (CLL)
    9. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    10. Update on Chronic Lymphocytic Leukemia (CLL)
      Part I of Living with Chronic Lymphocytic Leukemia (CLL)
    11. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    12. Living with Acute Myelogenous Leukemia (AML)
    13. Progress in the Treatment of Myelodysplastic Syndrome (MDS)
    14. Living with Chronic Myelogenous Leukemia (CML)
    15. Current Perspectives on the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
      Part II of Life with Chronic Lymphocytic Leukemia (CLL)
    16. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    17. Update on Chronic Lymphocytic Leukemia
      Part I of Life with Chronic Lymphocytic Leukemia (CLL)
    18. Taking Your Blood Cancer Treatment on Schedule
    19. Updates in the Treatment of Acute Myelogenous Leukemia
    20. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    21. Treatment Update for Adults Living with Acute Lymphocytic Leukemia (ALL)
    22. Life with CLL: Taking Charge of Your Treatment Schedule
      Part II of Life with Chronic Lymphocytic Leukemia (CLL)
    23. New Treatments for Childhood Acute Lymphocytic Leukemia (ALL)

For Liver Cancer

    1. Liver Cancer: Treatment Updates
    2. Treatment Update on Liver Cancer

For Lung Cancer

    1. Non-Small Cell Lung Cancer: What’s New
      Part I of Living with Non-Small Cell Lung Cancer
    2. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Equity. Every Patient. Every Day. Everywhere.
    3. Diverse Populations Living with Non-Small Cell Lung Cancer
    4. Advances in the Treatment of Lung Cancer
      Part I of Living with Lung Cancer
    5. Update on Small Cell Lung Cancer Treatments
    6. For Caregivers: Practical Tips for Coping with Your Loved One’s Lung Cancer
      Part II of Living with Lung Cancer
    7. Progress in the Treatment of Lung Cancer
      Part I of Living with Lung Cancer
    8. Advances in the Treatment of Lung Cancer
      Part I of Life with Lung Cancer
    9. For Caregivers: Practical Tips for Coping with Your Loved One’s Lung Cancer During the Holidays
      Part II of Life with Lung Cancer
    10. Progress in the Treatment of Lung Cancer
      Part I of Life with Lung Cancer

For Lymphoma

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    3. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Equity. Every Patient. Every Day. Everywhere.
    4. Transplantation as a Treatment Option for Blood Cancers
    5. Update on Marginal Zone Lymphoma (MZL)
    6. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    7. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    8. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
    9. Update on CAR T-Cell Therapies
    10. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    11. Treatment Update on Mantle Cell Lymphoma (MCL)
      Part I of Living with Mantle Cell Lymphoma
    12. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    13. Progress in the Treatment of Follicular Lymphoma
    14. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    15. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
    16. New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
    17. What’s New in the Treatment of Hodgkin Lymphoma
    18. Treatment Update on Mantle Cell Lymphoma (MCL)
    19. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    20. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    21. Taking Your Blood Cancer Treatment on Schedule
    22. The Latest News in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    23. Update on Diffuse Large B-Cell Lymphoma
    24. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    25. The Emerging Role of Immunotherapy in the Treatment of Lymphoma

For Mantle Cell Lymphoma

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    3. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    4. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    5. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
    6. Update on CAR T-Cell Therapies
    7. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    8. Treatment Update on Mantle Cell Lymphoma (MCL)
      Part I of Living with Mantle Cell Lymphoma
    9. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    10. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    11. Treatment Update on Mantle Cell Lymphoma (MCL)
    12. Update on CAR-T Cell Therapy
    13. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    14. Taking Your Blood Cancer Treatment on Schedule
    15. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    16. The Emerging Role of Immunotherapy in the Treatment of Lymphoma

For Marginal Zone Lymphoma

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    3. Update on Marginal Zone Lymphoma (MZL)
    4. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    5. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
    6. Update on CAR T-Cell Therapies
    7. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    8. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    9. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    10. Update on CAR-T Cell Therapy
    11. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    12. Taking Your Blood Cancer Treatment on Schedule
    13. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    14. The Emerging Role of Immunotherapy in the Treatment of Lymphoma

For Melanoma

    1. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Equity. Every Patient. Every Day. Everywhere.
    2. Emerging Treatments for Metastatic Melanoma
      Part II of Living with Advanced Skin Cancer and Melanoma
    3. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers
      Part I of Living with Advanced Skin Cancer and Melanoma
    4. Emerging Treatments for Metastatic Melanoma
      Part II of Life with Advanced Skin Cancer

For Merkel Cell Carcinoma

    1. Treatment Perspectives on Merkel Cell Carcinoma (MCC)
      Part I of Living with Merkel Cell Carcinoma (MCC)

For Mesothelioma

    1. Mesothelioma: Innovative Treatment Options
    2. Advances in the Treatment of Mesothelioma

For Metastatic Breast Cancer

    1. Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the San Antonio Breast Cancer Symposium (SABCS)
      Part II of Living with Breast Cancer, with Updates from the San Antonio Breast Cancer Symposium (SABCS)
    2. Updates from the 44th Annual San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer (TNBC)
    3. The Latest Developments Reported at the 44th Annual San Antonio Breast Cancer Symposium (SABCS)
      Part I of Living with Breast Cancer, with Updates from the San Antonio Breast Cancer Symposium (SABCS)
    4. HER2-Positive Metastatic Breast Cancer: New Therapies
    5. Metastatic Breast Cancer: Treatment Updates
    6. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part I of Equity. Every Patient. Every Day. Everywhere.
    7. Updates on the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive & HER2 Positive Breast Cancer from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
      Part II of Life with Breast Cancer - Updates from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
    8. The Latest Developments Reported from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
      Part I of Life with Breast Cancer - Updates from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
    9. Updates from the San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer (TNBC)
    10. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment
    11. Triple Negative Breast Cancer and African American Women
    12. What’s New in the Treatment of Breast Cancer for Women of All Ages
    13. What’s New in the Treatment of Metastatic Breast Cancer

For Multiple Myeloma

    1. Coping with the Stresses of Caregiving When Your Loved One Has Multiple Myeloma
      Part II of Living with Multiple Myeloma
    2. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    3. Progress in the Treatment of Multiple Myeloma
      Part I of Living with Multiple Myeloma
    4. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    5. Transplantation as a Treatment Option for Blood Cancers
    6. Update on CAR T-Cell Therapies
    7. Progress in the Treatment of Multiple Myeloma
    8. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    9. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    10. Progress in the Treatment of Multiple Myeloma
      Part I of Life with Multiple Myeloma
    11. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    12. Taking Your Blood Cancer Treatment on Schedule
    13. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

For Myelodysplastic Syndromes

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    3. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Equity. Every Patient. Every Day. Everywhere.
    4. Transplantation as a Treatment Option for Blood Cancers
    5. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    6. Update on CAR T-Cell Therapies
    7. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    8. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    9. Progress in the Treatment of Myelodysplastic Syndrome (MDS)
    10. Taking Your Blood Cancer Treatment on Schedule

For Myelofibrosis

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Transplantation as a Treatment Option for Blood Cancers
    3. Progress in the Treatment of Myelofibrosis
    4. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    5. Update on CAR T-Cell Therapies
    6. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    7. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    8. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    9. Taking Your Blood Cancer Treatment on Schedule
    10. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

For Myeloproliferative Neoplasms

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    3. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Equity. Every Patient. Every Day. Everywhere.
    4. Transplantation as a Treatment Option for Blood Cancers
    5. Progress in the Treatment of Myelofibrosis
    6. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    7. Update on CAR T-Cell Therapies
    8. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    9. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    10. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    11. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    12. Taking Your Blood Cancer Treatment on Schedule
    13. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

For Non-Hodgkin Lymphoma

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    3. Transplantation as a Treatment Option for Blood Cancers
    4. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    5. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    6. Update on CAR T-Cell Therapies
    7. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    8. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    9. Progress in the Treatment of Follicular Lymphoma
    10. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    11. Update on CAR-T Cell Therapy
    12. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    13. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    14. Taking Your Blood Cancer Treatment on Schedule
    15. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    16. The Emerging Role of Immunotherapy in the Treatment of Lymphoma

For Ovarian Cancer

    1. Ovarian Cancer: Treatment Updates
    2. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part I of Equity. Every Patient. Every Day. Everywhere.
    3. Medical Update on Ovarian Cancer
    4. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment

For Pancreatic Cancer

    1. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Equity. Every Patient. Every Day. Everywhere.
    2. Treatment Update on Pancreatic Cancer

For Peripheral T-Cell Lymphoma

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    3. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    4. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    5. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
    6. Update on CAR T-Cell Therapies
    7. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    8. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    9. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    10. New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
    11. Update on CAR-T Cell Therapy
    12. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    13. Taking Your Blood Cancer Treatment on Schedule
    14. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    15. The Emerging Role of Immunotherapy in the Treatment of Lymphoma

For Polycythemia Vera

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Transplantation as a Treatment Option for Blood Cancers
    3. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    4. Update on CAR T-Cell Therapies
    5. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    6. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    7. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    8. Taking Your Blood Cancer Treatment on Schedule
    9. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    10. The Emerging Role of Immunotherapy in the Treatment of Lymphoma

For Prostate Cancer

    1. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part I of Equity. Every Patient. Every Day. Everywhere.
    2. Advances in the Treatment of Metastatic Prostate Cancer
    3. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment

For Renal Cell Cancer

    1. Advances in the Treatment of Renal Cell Cancer

For Sarcoma

    1. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part I of Equity. Every Patient. Every Day. Everywhere.
    2. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment
    3. Update on Soft Tissue Sarcoma
    4. Update on Rare Sarcomas

For Skin Cancer

    1. Emerging Treatments for Metastatic Melanoma
      Part II of Living with Advanced Skin Cancer and Melanoma
    2. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers
      Part I of Living with Advanced Skin Cancer and Melanoma
    3. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers
    4. Emerging Treatments for Metastatic Melanoma
      Part II of Life with Advanced Skin Cancer
    5. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers
      Part I of Life with Advanced Skin Cancer
    6. Treatment Perspectives on Merkel Cell Carcinoma (MCC)
      Part I of Living with Merkel Cell Carcinoma (MCC)

For Small Lymphocytic Lymphoma

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    3. Transplantation as a Treatment Option for Blood Cancers
    4. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    5. Update on CAR T-Cell Therapies
    6. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    7. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    8. Update on CAR-T Cell Therapy
    9. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    10. Taking Your Blood Cancer Treatment on Schedule
    11. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    12. The Emerging Role of Immunotherapy in the Treatment of Lymphoma

For Squamous Cell Cancer

    1. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers
      Part I of Living with Advanced Skin Cancer and Melanoma
    2. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers
    3. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers
      Part I of Life with Advanced Skin Cancer

For Stomach Cancer

    1. Gastric Cancer: Treatment Updates
    2. Current Perspectives in the Treatment of Metastatic Gastric Cancer

For Thyroid Cancer

For Triple Negative Breast Cancer

    1. Updates from the 44th Annual San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer (TNBC)
    2. The Latest Developments Reported at the 44th Annual San Antonio Breast Cancer Symposium (SABCS)
      Part I of Living with Breast Cancer, with Updates from the San Antonio Breast Cancer Symposium (SABCS)
    3. Triple Negative Breast Cancer and African American Women
    4. HER2-Positive Metastatic Breast Cancer: New Therapies
    5. Metastatic Breast Cancer: Treatment Updates
    6. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part I of Equity. Every Patient. Every Day. Everywhere.
    7. Updates on the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive & HER2 Positive Breast Cancer from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
      Part II of Life with Breast Cancer - Updates from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
    8. The Latest Developments Reported from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
      Part I of Life with Breast Cancer - Updates from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
    9. Updates from the San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer (TNBC)
    10. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment
    11. Triple Negative Breast Cancer and African American Women
    12. What’s New in the Treatment of Breast Cancer for Women of All Ages

For Uterine Cancer

    1. Update on the Treatment of Endometrial Cancer

For Waldenstrom’s Macroglobulinemia

    1. Transplantation as a Treatment Option for Blood Cancers
    2. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    3. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    4. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    5. The Latest News in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    6. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
Back to Top
Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.